{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:25:11Z","timestamp":1787235911957,"version":"build-2736575974"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Pharmacoepidemiological research about antibiotics is supported by the World Health Organization (WHO), but data regarding antibiotic prevalence based on actual prescriptions and dosing patterns are insufficient. The aims were: (i) To estimate the prevalence and prescribed daily dose (PDD) of antibiotics in outpatients from Mexico City and (ii) to compare the PDD against the defined daily dose (DDD), as established by the WHO. The study included 685 prescriptions of antibiotics selected randomly from five geographical zones of Mexico City. Drug, dose, frequency, and duration of treatment were obtained from each prescription. PDD values of each antibiotic drug were calculated as the average of the daily doses. Sub-use and overuse were determined by the ratio PDD\/DDD for each prescription. The most prescribed antibiotics to outpatients from Mexico City included six pharmacological groups: quinolones (28%), penicillins (23%), cephalosporins (17%), macrolides (10%), lincosamides (9%), and sulfonamides (4%). Both overuse and sub-use were high (55% and 63%, respectively). In conclusion, most of the antibiotics with a high prevalence of prescription also had a high rate of either sub-use or overuse, with prescribed doses that significantly differ with their corresponding DDD. The dosing variation has important clinical implications since it denotes low prescription control.<\/jats:p>","DOI":"10.3390\/antibiotics9010038","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T04:27:09Z","timestamp":1579494429000},"page":"38","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City"],"prefix":"10.3390","volume":"9","author":[{"given":"Ramiro","family":"S\u00e1nchez-Huesca","sequence":"first","affiliation":[{"name":"CEBECI Farmacolog\u00eda Cl\u00ednica Sociedad Civil, 06700 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-641X","authenticated-orcid":false,"given":"Abel","family":"Lerma","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidad Aut\u00f3noma del Estado de Hidalgo, 42160 San Juan Tilcuautla, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-4871","authenticated-orcid":false,"given":"Rebeca M.E","family":"Guzm\u00e1n-Salda\u00f1a","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Universidad Aut\u00f3noma del Estado de Hidalgo, 42160 San Juan Tilcuautla, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4679-7751","authenticated-orcid":false,"given":"Claudia","family":"Lerma","sequence":"additional","affiliation":[{"name":"Department of Electromechanical Instrumentation, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez, 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S480","DOI":"10.1590\/S0036-36342008001000009","article-title":"Antibiotic use in Mexico: Review of problems and policies","volume":"50","author":"Dreser","year":"2008","journal-title":"Salud Publica Mex."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dreser, A., V\u00e1zquez-V\u00e9lez, E., Trevi\u00f1o, S., and Wirtz, V.J. (2012). Regulation of antibiotic sales in Mexico: An analysis of printed media coverage and stakeholder participation. BMC Public Health, 12.","DOI":"10.1186\/1471-2458-12-1051"},{"key":"ref_3","first-page":"499","article-title":"Antibiotic stewardship","volume":"13","author":"Hand","year":"2013","journal-title":"Clin. Med. J. R. Coll. Phys. Lond."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.diagmicrobio.2008.02.012","article-title":"Antimicrobial stewardship: Concepts and strategies in the 21st century","volume":"61","author":"Owens","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bell, B.G., Schellevis, F., Stobberingh, E., Goossens, H., and Pringle, M. (2014). A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-13"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/zph.12166","article-title":"A collaborative initiative for the containment of antimicrobial resistance in Mexico","volume":"62","author":"Zaidi","year":"2015","journal-title":"Zoonoses Public Health"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"De, J., Sosa, A., Byarugaba, D.K., Amabile-Cuevas, C.F., Hsueh, P.R., Kariuki, S., and Okeke, I.N. (2010). Antimicrobial Resistance in Developing Countries, Springer.","DOI":"10.1007\/978-0-387-89370-9"},{"key":"ref_8","first-page":"215","article-title":"An\u00e1lisis sistem\u00e1tico de la utilizaci\u00f3n de antibi\u00f3ticos como estrategia \u00fatil para mejorar la calidad de la prescripci\u00f3n","volume":"26","year":"2002","journal-title":"Farm. Hosp."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S1098-3597(03)90025-1","article-title":"Antibiotics and collateral damage","volume":"5","author":"Hoban","year":"2003","journal-title":"Clin. Cornerstone"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"\u201cCollateral Damage\u201d from Cephalosporin or Quinolone Antibiotic Therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Coyne, L., Arief, R., Benigno, C., Giang, V.N., Huong, L.Q., Jeamsripong, S., Kalpravidh, W., McGrane, J., Padungtod, P., and Patrick, I. (2019). Characterizing antimicrobial use in the livestock sector in three South East Asian countries (Indonesia, Thailand, and Vietnam). Antibiotics, 8.","DOI":"10.3390\/antibiotics8010033"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Holmes, E.A.F., and Hughes, D.A. (2019). Challenges for economic evaluation of health care strategies to contain antimicrobial resistance. Antibiotics, 8.","DOI":"10.3390\/antibiotics8040166"},{"key":"ref_13","unstructured":"Secretar\u00eda de Salud de los Estados Unidos Mexicanos (2010). Acuerdo por el que se Determinan los Lineamientos a los que Estar\u00e1 Sujeta la Venta y Dispensaci\u00f3n de Antibi\u00f3ticos, Diario Oficial de la Federaci\u00f3n."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-013-1619-0","article-title":"The quality of outpatient antimicrobial prescribing: A comparison between two areas of northern and southern Europe","volume":"70","author":"Malo","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pds.3831","article-title":"Prevalence of antibiotic use: A comparison across various European health care data sources","volume":"25","author":"Brauer","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/pds.1082","article-title":"International Society of Pharmacoepidemiology Guidelines for good pharmacoepidemiology practices (GPP)","volume":"14","author":"Epstein","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_17","unstructured":"The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) (2010). Guide on Methodological Standards in Pharmacoepidemiology, European Medicines Agency. Revision 5; EMA\/95098\/2010."},{"key":"ref_18","first-page":"6","article-title":"Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico","volume":"8","author":"Dreser","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data","volume":"14","author":"Gandra","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3855\/jidc.427","article-title":"Antibiotic resistance in Mexico: A brief overview of the current status and its causes","volume":"4","year":"2010","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_21","first-page":"9","article-title":"Mexican pharmacies and antibiotic consumption at the US-Mexico border","volume":"5","author":"Homedes","year":"2012","journal-title":"South. Med Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1478-4491-7-54","article-title":"The role of pharmacists in developing countries: The current scenario in Pakistan","volume":"7","author":"Azhar","year":"2009","journal-title":"Hum. Resour. Health"},{"key":"ref_23","first-page":"169","article-title":"The prescription of drugs in a dental clinic of a Mexican university hospital","volume":"31","year":"2007","journal-title":"Farm. Hosp."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among us ambulatory care visits, 2010\u20132011","volume":"315","author":"Hersh","year":"2016","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.curtheres.2007.03.005","article-title":"Resistance of uropathogenic bacteria to first-line antibiotics in mexico city: A multicenter susceptibility analysis","volume":"68","year":"2007","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_26","first-page":"239","article-title":"Microbiology of urinary tract infections in ambulatory patients. Therapeutic options in times of high antibiotic resistance","volume":"59","author":"Cebada","year":"2007","journal-title":"Rev. Investig. Clin."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/antibiotics3030450","article-title":"A point prevalence survey of antibiotic use in 18 hospitals in Egypt","volume":"3","author":"Talaat","year":"2014","journal-title":"Antibiotics"},{"key":"ref_28","unstructured":"Masson-Salvat, E. (2003). Principios de Epidemiolog\u00eda del Medicamento, UAB. [2nd ed.]."},{"key":"ref_29","unstructured":"Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), and Center for Briologics Evaluation and Research (CBER) (2005). Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment, FDA."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3399\/bjgp09X472593","article-title":"Which practices are high antibiotic prescribers? A cross-sectional analysis","volume":"59","author":"Wang","year":"2009","journal-title":"Br. J. Gen. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/pds.852","article-title":"Drug utilisation 90% profiles\u2014A useful tool for quality assessment of prescribing in primary health care in Stockholm","volume":"12","author":"Wettermark","year":"2003","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sosa, A.J., Byarugaba, D.K., Am\u00e1bile-Cuevas, C., Hsueh, P.R., Kariuki, S., and Okeke, I. (2010). Global perspectives of antibiotic resistance. Antimicrobial Resistance in Developing Countries, Springer.","DOI":"10.1007\/978-0-387-89370-9"},{"key":"ref_33","unstructured":"World Health Organization (2014). Antimicrobial Resistance: Global Report on Surveillance, World Health Organization."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/pds.2079","article-title":"Definition of patients treated with evidence based drugs in absence of prescribed daily doses: The example of acute myocardial infarction","volume":"20","author":"Belleudi","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_35","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology and Norwegian Institute of Public Health (2018). Guidelines for ATC Classification and DDD Assignment, World Health Organization Press."},{"key":"ref_36","unstructured":"Product Lifecycle Management (PLM) (2019). Informaci\u00f3n para Prescribir Ampliada (IPPA), Bactrim Forte (Roche). Ediciones PLM."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00228-011-1014-7","article-title":"Discrepancies between prescribed and defined daily doses: A matter of patients or drug classes?","volume":"67","author":"Grimmsmann","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2125.2006.02605.x","article-title":"Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital","volume":"61","author":"Muller","year":"2006","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/9\/1\/38\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:44:06Z","timestamp":1760363046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/9\/1\/38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["antibiotics9010038"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics9010038","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]}}}